Ferriere JP - Search Results

1

Does survival increase in metastatic breast cancer with recently available anticancer drugs?

Abrial C, Leheurteur M, Cabrespine A, Mouret-Reynier MA, Durando X, Ferriere JP, Kwiatkowski F, Penault-Llorca F, Cure H, Chollet P. Abrial C, et al. Among authors: ferriere jp. Oncol Res. 2006;15(9):431-9. doi: 10.3727/096504005776568264. Oncol Res. 2006. PMID: 16555549

2

Prognostic value of residual node involvement in operable breast cancer after induction chemotherapy.

Curé H, Amat S, Penault-Llorca F, le Bouëdec G, Ferrière JP, Mouret-Reynier MA, Kwiatkowski F, Feillel V, Dauplat J, Chollet P. Curé H, et al. Among authors: ferriere jp. Breast Cancer Res Treat. 2002 Nov;76(1):37-45. doi: 10.1023/a:1020274709327. Breast Cancer Res Treat. 2002. PMID: 12408374

3

Neoadjuvant FEC 100 for operable breast cancer: eight-year experience at Centre Jean Perrin.

Mouret-Reynier MA, Abrial CJ, Ferrière JP, Amat S, Curé HD, Kwiatkowski FG, Feillel VA, Lebouëdec G, Penault-Llorca FM, Chollet PJ. Mouret-Reynier MA, et al. Among authors: ferriere jp. Clin Breast Cancer. 2004 Oct;5(4):303-7. doi: 10.3816/cbc.2004.n.035. Clin Breast Cancer. 2004. PMID: 15507178 Clinical Trial.

4

[Indications, contra-indications, expected results and choice of neoadjuvant chemotherapy for operable breast cancer].

Mouret-Reynier MA, Abrial C, Leheurteur M, Durando X, Van Praagh I, Gimbergues P, Achard JL, Ferrière JP, Cure H, Chollet P. Mouret-Reynier MA, et al. Among authors: ferriere jp. Bull Cancer. 2006 Nov;93(11):1121-9. Bull Cancer. 2006. PMID: 17145582 Free article. Review. French.

5

Comparative review of anastrozole, letrozole and exemestane in the management of early breast cancer.

Nabholtz JM, Mouret-Reynier MA, Durando X, Van Praagh I, Al-Sukhun S, Ferriere JP, Chollet P. Nabholtz JM, et al. Among authors: ferriere jp. Expert Opin Pharmacother. 2009 Jun;10(9):1435-47. doi: 10.1517/14656560902953738. Expert Opin Pharmacother. 2009. PMID: 19445563 Review.

6

Adjuvant chemotherapy with doxorubicin-containing regimen for 326 stage II breast cancers: 15-year results.

Ferrière JP, Charrier S, Curé H, Kwiatkowski F, Courtadon M, Bélembaogo E, de Latour M, Achard JL, Dauplat J, Chollet P. Ferrière JP, et al. Am J Clin Oncol. 1997 Jun;20(3):219-25. doi: 10.1097/00000421-199706000-00001. Am J Clin Oncol. 1997. PMID: 9167740

7

Primary chemotherapy in breast cancer: correlation between tumor response and patient outcome.

Ferrière JP, Assier I, Curé H, Charrier S, Kwiatkowski F, Achard JL, Dauplat J, Chollet P. Ferrière JP, et al. Am J Clin Oncol. 1998 Apr;21(2):117-20. doi: 10.1097/00000421-199804000-00003. Am J Clin Oncol. 1998. PMID: 9537193

8

Prognostic value of initial tumor parameters after metastatic relapse.

Planchat E, Durando X, Abrial C, Thivat E, Mouret-Reynier MA, Ferrière JP, Pomel C, Kwiatkowski F, Chollet P, Nabholtz JM. Planchat E, et al. Among authors: ferriere jp. Cancer Invest. 2011 Nov;29(9):635-43. doi: 10.3109/07357907.2011.621911. Cancer Invest. 2011. PMID: 22011286

9

O(6)-methylguanine-DNA methyl transferase gene expression and prognosis in breast carcinoma.

Cayre A, Penault-Llorca F, De Latour M, Rolhion C, Feillel V, Ferrière JP, Kwiatkowski F, Finat-Duclos F, Verrelle P. Cayre A, et al. Among authors: ferriere jp. Int J Oncol. 2002 Nov;21(5):1125-31. Int J Oncol. 2002. PMID: 12370764

10

Induction chemotherapy for breast carcinoma: predictive markers and relation with outcome.

Penault-Llorca F, Cayre A, Bouchet Mishellany F, Amat S, Feillel V, Le Bouedec G, Ferrière JP, De Latour M, Chollet P. Penault-Llorca F, et al. Among authors: ferriere jp. Int J Oncol. 2003 Jun;22(6):1319-25. Int J Oncol. 2003. PMID: 12739000

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

39 results

Search Page

Filters